This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow P3Rs: Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when P3Rs are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow E-mail this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My File Cabinet
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via CrossRef
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Mrena, S.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Mrena, S.
Related Collections
Right arrow Endocrinology

PEDIATRICS Vol. 104 No. 4 October 1999, pp. 925-930

Staging of Preclinical Type 1 Diabetes in Siblings of Affected Children

Received Jan 4, 1999; accepted Apr 8, 1999.

Samy Mrena*, Kaisa SavolaDagger , Petri KulmalaDagger , Hans K. Åkerblom§, Mikael Knip*, and the Childhood Diabetes in Finland Study Group

From the * Medical School, University of Tampere, Department of Pediatrics, Tampere University Hospital, and Tampere Diabetes Research Center, Tampere; the Dagger  Department of Pediatrics, University of Oulu, Oulu; and § Hospital for Children and Adolescents, University of Helsinki, Helsinki, Finland.

Objectives.  To assess whether it is clinically relevant to classify siblings of children with recent-onset type 1 diabetes mellitus (T1DM) into various stages of preclinical diabetes, and to compare the risk of developing clinical disease and the time to diagnosis between these stages.

Study Design.  From a total of 801 families taking part in the Childhood Diabetes in Finland Study, 758 initially unaffected siblings were graded into four stages of preclinical T1DM based on the number of disease-associated autoantibodies detectable close to the time of diagnosis in the index case: no (no antibodies), early (one antibody specificity), advanced (two antibodies), and late prediabetes (more than three antibodies). Another classification system, used with 712 siblings, was based on a combination of the number of antibodies and the first-phase insulin response (FPIR) to intravenous glucose: no (no antibodies), early (one antibody specificity, normal FPIR), advanced (two or more antibodies, normal FPIR), and late prediabetes (one or more antibodies, reduced FPIR).

Results.  Six out of 661 siblings who initially presented no signs of prediabetes (0.9%; 95% confidence interval [CI], 0.3%-2.0%) progressed to clinical T1DM. Based on the first set of criteria, 3 out of 49 individuals (6.1%; CI, 1.3%-16.9%; odds ratio [OR], 7.1; CI, 1.7-29.4) from the early prediabetes category, 3 out of 13 with advanced prediabetes (23.1%; CI, 5.0%-53.8%; OR, 32.8; CI, 7.2-150), and 23 out of 35 with late prediabetes (65.7%; CI, 47.8%-80.9%; OR, 209; CI, 72.2-607) presented with clinical signs of T1DM. According to the second set of criteria 1 out of 15 siblings with early prediabetes (6.7%; CI, 0.2%-32.0%; OR, 7.8; CI, 0.9-69.1), 6 out of 23 with advanced prediabetes (26.1%; CI, 10.2%-48.4%; OR, 38.5; CI, 11.3-132), and 12 out of 13 with late prediabetes (92.3%; CI, 64.0%-99.8%; OR, 1310; CI, 146-11 737) presented with clinical signs of T1DM. The time to diagnosis was significantly shorter in those with late prediabetes initially than in those with no signs of prediabetes.

Conclusions.  Our observations indicate that it is possible to grade siblings of children with newly diagnosed T1DM into categories with significant differences in the subsequent risk of clinical T1DM and time to diagnosis. Such a classification will become clinically relevant as soon as effective measures are available for preventing or delaying the manifestation of overt T1DM.autoantibodies, classification, prospective, first-phase insulin response. .




This article has been cited by other articles:


Home page
 Diabetes CareHome page
S. Mrena, S. M. Virtanen, P. Laippala, P. Kulmala, M.-L. Hannila, H. K. Akerblom, M. Knip, and the Childhood Diabetes in Finland Study Group
Models for predicting type 1 diabetes in siblings of affected children.
Diabetes Care, March 1, 2006; 29(3): 662 - 667.
[Abstract] [Full Text] [PDF]

Home page
 DiabetesHome page
N. A. Sherry, E. B. Tsai, and K. C. Herold
Natural History of {beta}-Cell Function in Type 1 Diabetes
Diabetes, December 1, 2005; 54(suppl_2): S32 - S39.
[Abstract] [Full Text] [PDF]

Home page
 J. Clin. Endocrinol. Metab.Home page
S. Mrena, K. Savola, P. Kulmala, H. Reijonen, J. Ilonen, H. K. Akerblom, and M. Knip
Genetic Modification of Risk Assessment Based on Staging of Preclinical Type 1 Diabetes in Siblings of Affected Children
J. Clin. Endocrinol. Metab., June 1, 2003; 88(6): 2682 - 2689.
[Abstract] [Full Text] [PDF]